China Companion Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, Equine), By Product (Pharmaceuticals, Diagnostics), By Distribution Channel (Retail, E-commerce), By End-use (Hospitals & Clinics), And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Research Methodology
                    1.3. Information Procurement
                    1.4. Information or Data Analysis
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Data Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. China Companion Animal Health Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Rising prevalence of pet diseases
                            3.2.1.2. Growing uptake of pet insurance
                            3.2.1.3. Increasing pet population
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. High cost of advanced treatment
                        3.2.3. Market Opportunity Analysis
                        3.2.4. Market Challenge Analysis
                    3.3. China Companion Animal Health Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political & Legal landscape
                            3.3.2.2. Economic and Social landscape
                            3.3.2.3. Technological landscape
                        3.3.3. Regulatory Framework
                        3.3.4. Pricing Analysis
                        3.3.5. Product Pipeline Analysis
                        3.3.6. Estimated Number of pet popultion in China, 2018-2024
                        3.3.7. COVID-19 Impact Analysis
Chapter 4. China Companion Animal Health Market: Animal type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. China Companion Animal Health Market: Animal type Movement Analysis & Market Share, 2024 & 2030
                    4.3. Dogs
                        4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Cats
                        4.4.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Equine
                        4.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Others
                        4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. China Companion Animal Health Market: Product Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. China Companion Animal Health Market: Product Movement Analysis & Market Share, 2024 & 2030
                    5.3. Biologics
                        5.3.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.2. Vaccines
                            5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.2. Modified/ Attenuated Live
                                5.3.2.2.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.3. Inactivated (Killed)
                                5.3.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.4. Other Vaccines
                                5.3.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.3. Other Biologics
                            5.3.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.4. Pharmaceuticals
                        5.4.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.2. Parasiticides
                            5.4.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.3. Anti-infectives
                            5.4.3.1. Anti-Infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.4. Anti-Inflammatory
                            5.4.4.1. Anti-Inflammatory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.5. Analgesics
                            5.4.5.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.6. Others
                            5.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Supplements
                        5.5.1. Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Diagnostics
                        5.6.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.7. Others
                        5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. China Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. China Companion Animal Health Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
                    6.3. Retail
                        6.3.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.4. E-Commerce
                        6.4.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Hospital/ Clinic Pharmacies
                        6.5.1. Hospital/ Clinic Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. China Companion Animal Health Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. China Companion Animal Health Market: End Use Movement Analysis & Market Share, 2024 & 2030
                    7.3. Hospitals & Clinics
                        7.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.2. Point-of-Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Others
                        7.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Company Market Position Analysis/ Heap Map Analysis
                    8.3. Company Profiles
                        8.3.1. Boehringer Ingelheim International GmbH
                            8.3.1.1. Participant’s Overview
                            8.3.1.2. Financial Performance
                            8.3.1.3. Product Benchmarking
                            8.3.1.4. Strategic Initiatives
                        8.3.2. Elanco
                            8.3.2.1. Participant’s Overview
                            8.3.2.2. Financial Performance
                            8.3.2.3. Product Benchmarking
                            8.3.2.4. Strategic Initiatives
                        8.3.3. Merck & Co., Inc.
                            8.3.3.1. Participant’s Overview
                            8.3.3.2. Financial Performance
                            8.3.3.3. Product Benchmarking
                            8.3.3.4. Strategic Initiatives
                        8.3.4. Zoetis
                            8.3.4.1. Participant’s Overview
                            8.3.4.2. Financial Performance
                            8.3.4.3. Product Benchmarking
                            8.3.4.4. Strategic Initiatives
                        8.3.5. Ceva
                            8.3.5.1. Participant’s Overview
                            8.3.5.2. Financial Performance
                            8.3.5.3. Product Benchmarking
                            8.3.5.4. Strategic Initiatives
                        8.3.6. Virbac
                            8.3.6.1. Participant’s Overview
                            8.3.6.2. Financial Performance
                            8.3.6.3. Product Benchmarking
                            8.3.6.4. Strategic Initiatives
                        8.3.7. Bimeda, Inc.
                            8.3.7.1. Participant’s Overview
                            8.3.7.2. Financial Performance
                            8.3.7.3. Product Benchmarking
                            8.3.7.4. Strategic Initiatives
                        8.3.8. IDEXX Laboratories
                            8.3.8.1. Participant’s Overview
                            8.3.8.2. Financial Performance
                            8.3.8.3. Product Benchmarking
                            8.3.8.4. Strategic Initiatives
                        8.3.9. Thermo Fisher Scientific
                            8.3.9.1. Participant’s Overview
                            8.3.9.2. Financial Performance
                            8.3.9.3. Product Benchmarking
                            8.3.9.4. Strategic Initiatives
                        8.3.10. Randox Laboratories
                            8.3.10.1. Participant’s Overview
                            8.3.10.2. Financial Performance
                            8.3.10.3. Product Benchmarking
                            8.3.10.4. Strategic Initiatives
                    8.4. List of Other Key Players

List of Tables

Table 1. List of secondary sources
Table 2. China Companion Animal Health market, by animal type , 2018 - 2030 (USD Million)
Table 3. China Companion Animal Health market, by Product , 2018 - 2030 (USD Million)
Table 4. China Companion Animal Health market, by Biologics, 2018 - 2030 (USD Million)
Table 5. China Companion Animal Health market, by Pharmaceuticals, 2018 - 2030 (USD Million)
Table 6. China Companion Animal Health market, by Supplements, 2018 - 2030 (USD Million)
Table 7. China Companion Animal Health market, by Diagnostics, 2018 - 2030 (USD Million)
Table 8. China Companion Animal Health market, by Others , 2018 - 2030 (USD Million)
Table 9. China Companion Animal Health market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10. China Companion Animal Health market, by End Use, 2018 - 2030 (USD Million)
Table 11. Participant’s overview
Table 12. Financial performance
Table 13. Product benchmarking
Table 14. Strategic Initiatives

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 China Companion Animal Health market revenue, 2018 - 2030 (USD Million)
Fig. 10 China Companion Animal Health market snapshot
Fig. 11 China Companion Animal Health market driver impact
Fig. 12 China Companion Animal Health market restraint impact
Fig. 13 Porter’s 5 Forces Analysis
Fig. 14 PESTEL Analysis
Fig. 15 China Companion Animal Health market animal type key takeaways (USD Million)
Fig. 16 China Companion Animal Health market: animal type movement analysis
Fig. 17 China dogs market, 2018 - 2030 (USD Million)
Fig. 18 China cats market, 2018 - 2030 (USD Million)
Fig. 19 China equine market, 2018 - 2030 (USD Million)
Fig. 20 China others market, 2018 - 2030 (USD Million)
Fig. 21 China Companion Animal Health product key takeaways (USD Million)
Fig. 22 China Companion Animal Health market: product movement analysis
Fig. 23 China biologics market, 2018 - 2030 (USD Million)
Fig. 24 China vaccines market, 2018 - 2030 (USD Million)
Fig. 25 China Modified/ Attenuated Live market, 2018 - 2030 (USD Million)
Fig. 26 China Inactivated (Killed) market, 2018 - 2030 (USD Million)
Fig. 27 China Other vaccines market, 2018 - 2030 (USD Million)
Fig. 28 China other biologics market, 2018 - 2030 (USD Million)
Fig. 29 China pharamceuticals market, 2018 - 2030 (USD Million)
Fig. 30 China parasiticides market, 2018 - 2030 (USD Million)
Fig. 31 China Anti-infectives market, 2018 - 2030 (USD Million)
Fig. 32 China Anti-inflammatory market, 2018 - 2030 (USD Million)
Fig. 33 China Analgesics market, 2018 - 2030 (USD Million)
Fig. 34 China supplements market, 2018 - 2030 (USD Million)
Fig. 35 China diagnostics market, 2018 - 2030 (USD Million)
Fig. 36 China others market, 2018 - 2030 (USD Million)
Fig. 37 China Companion Animal Health market distribution channel key takeaways (USD Million)
Fig. 38 China Companion Animal Health market: distribution channel movement analysis
Fig. 39 China retail market, 2018 - 2030 (USD Million)
Fig. 40 China e-commerce market, 2018 - 2030 (USD Million)
Fig. 41 China Hospital/ Clinic Pharmacies market, 2018 - 2030 (USD Million)
Fig. 42 China Companion Animal Health market end use key takeaways (USD Million)
Fig. 43 China Companion Animal Health market: end use movement analysis
Fig. 44 China Hospitals & Clinics market, 2018 - 2030 (USD Million)
Fig. 45 China Point-of-Care market, 2018 - 2030 (USD Million)
Fig. 46 China others market, 2018 - 2030 (USD Million)
Fig. 47 Market participant categorization
Fig. 48 Heat map analysis/Company market position analysis